MedPath

Bromhexine

Generic Name
Bromhexine
Drug Type
Small Molecule
Chemical Formula
C14H20Br2N2
CAS Number
3572-43-8
Unique Ingredient Identifier
Q1J152VB1P

Overview

Bromhexine is mucolytic agent used for a variety of respiratory conditions associated with increased mucus secretion. It is derived from the Adhatoda vasica plant and aids in the clearance of excess mucus, improving breathing and reducing cough. It was introduced into the market in 1963, and is widely available as an over-the-counter drug in many countries. Recently, bromhexine and its metabolite ambroxol have garnered interest for the potential prevention and treatment of COVID-19 due to their interactions with cell receptors in the lungs.

Indication

Bromohexine is used alone or with other ingredients such as diphenhydramine, dextromethorphan, and guaifenesin to reduce mucus viscosity and clear mucus in conditions associated with mucus hypersecretion, including the common cold, influenza, respiratory tract infections, or other conditions.

Associated Conditions

  • Bronchiectasis
  • Common Cold
  • Cough
  • Cough caused by Common Cold
  • Nasal Congestion
  • Whooping Cough

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2020/12/17
Phase 1
Completed
Second Affiliated Hospital of Wenzhou Medical University
2020/06/09
Phase 3
UNKNOWN
Lomonosov Moscow State University Medical Research and Educational Center
2020/05/28
Phase 4
Completed
Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health
2020/04/21
Phase 4
UNKNOWN
General and Teaching Hospital Celje
2020/04/09
Early Phase 1
UNKNOWN
2020/02/18
Not Applicable
UNKNOWN
Second Affiliated Hospital of Wenzhou Medical University

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
VASICAN TABLET 8 mg
SIN02528P
TABLET
8 mg
4/18/1989
BROMXINE TABLET 8 mg
ATLANTIC LABORATORIES CORPN LTD
SIN09127P
TABLET
8 mg
1/13/1997
VASICAN SYRUP 4 MG/5ML
SIN02864P
SYRUP
4 mg/5 ml
5/22/1989
BROMHEXINE TABLET 8 mg
SIN02479P
TABLET
8 mg
3/6/1989
AXCEL BROMHEXINE TABLET 8 mg
SIN10906P
TABLET
8 mg
4/30/1999
MUCOLIX ELIXIR 4 mg/5 ml
SIN02846P
ELIXIR
4 mg/5 ml
5/22/1989
BISLAN TABLET 8 mg
SIN10582P
TABLET
8 mg
12/22/1998
BROMHEXINE ELIXIR 4 mg/5 ml
SIN02468P
ELIXIR
4 mg/5 ml
2/27/1989
HOSOLVON TABLET 8 mg
SIN05034P
TABLET
8.00mg
8/30/1990
DURO-TUSS CHESTY COUGH LIQUID
SIN10014P
SOLUTION
12 mg/15 ml
9/21/1998

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
Bromhexine Hydrochloride Injection
国药准字H20213214
化学药品
注射剂
3/23/2021
Bromhexine Hydrochloride Injection
国药准字H20223868
化学药品
注射剂
11/22/2022
Bromhexine Hydrochloride Injection
国药准字H11022093
化学药品
注射剂(小容量注射剂)
11/2/2020
Bromhexine Hydrochloride Injection
国药准字H20233628
化学药品
注射剂
5/29/2023
Bromhexine Hydrochloride Injection
国药准字H20234640
化学药品
注射剂
12/13/2023
Bromhexine Hydrochloride Injection
国药准字H20243551
化学药品
注射剂
4/24/2024
Bromhexine Hydrochloride Injection
国药准字H20234075
化学药品
注射剂
8/29/2023
Bromhexine Hydrochloride Injection
国药准字H20244392
化学药品
注射剂
7/9/2024
Bromhexine Hydrochloride Injection
国药准字H20223720
化学药品
注射剂
11/23/2022
Bromhexine Hydrochloride Injection
国药准字H20244991
化学药品
注射剂
9/26/2024

PPB Drug Approvals

Help Us Improve

Your feedback helps us provide better drug information and insights.

© Copyright 2025. All Rights Reserved by MedPath